iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers
09 8월 2023 - 8:30PM
iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”),
an online global marketplace that connects scientists requiring
biospecimens for medical research with a network of healthcare
specimen providers, today announced that the Company has added a
new functionality to its proprietary iSpecimen Marketplace®
platform to simplify how researchers find and acquire highly
annotated, clinically collected remnant samples, which are leftover
biospecimens from those collected for clinical or diagnostic
purposes.
Historically, remnant samples have been sourced
from hospital labs and are typically limited in terms of the types
of samples and test data. With this update, the iSpecimen
Marketplace now displays real-time remnant sample requests from
researchers, enabling them to effectively source and obtain a wider
offering of necessary remnants from a large number of suppliers
within iSpecimen’s network. This includes suppliers that typically
provide banked or prospective samples but may not be aware of
requests for remnant materials. In this way, iSpecimen’s
Marketplace provides researchers with more complex and
well-annotated sample orders.
Additionally, since biorepository sites may have
leftover samples stored from prospective collections, these sites
may have more expansive data and can provide samples at a lower
cost. The sites also generally have these samples stored
on-location and are ready to ship, which streamlines workflow and
improves sample order fulfillment speed.
“Our latest Marketplace enhancement enables us
to address the ongoing issues in remnant sample procurement and
streamline fulfillment timelines for both researchers and
suppliers,” said Tracy Curley, iSpecimen’s CEO. “Now more than ever
– and especially with the rise of precision medicine – researchers
need highly specific samples and are often up against roadblocks
when putting in these types of requests. Our technology is
specifically designed to ease this burden and provide robust
samples in a way that has never been more efficient.”
About iSpecimeniSpecimen
(Nasdaq: ISPC) offers an online marketplace for human biospecimens,
connecting scientists in commercial and non-profit organizations
with healthcare providers that have access to patients and
specimens needed for medical discovery. Proprietary, cloud-based
technology enables scientists to intuitively search for specimens
and patients across a federated partner network of hospitals, labs,
biobanks, blood centers and other healthcare organizations. For
more information, please visit www.ispecimen.com.
Forward Looking Statements
This press release may contain forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Such forward-looking statements are
characterized by future or conditional verbs such as "may," "will,"
"expect," "intend," "anticipate," “believe," "estimate" and
"continue" or similar words. You should read statements that
contain these words carefully because they discuss future
expectations and plans, which contain projections of future results
of operations or financial condition or state other forward-looking
information.
Forward-looking statements are predictions,
projections and other statements about future events that are based
on current expectations and assumptions and, as a result, are
subject to risks and uncertainties. Many factors could cause actual
future events to differ materially from the forward-looking
statements in this press release, including but not limited to the
risk factors contained in the Company's filings with the Securities
and Exchange Commission, which are available for review at
www.sec.gov. Forward-looking statements speak only as of the date
they are made. New risks and uncertainties arise over time, and it
is not possible for the Company to predict those events or how they
may affect the Company. If a change to the events and circumstances
reflected in the Company's forward-looking statements occurs, the
Company's business, financial condition and operating results may
vary materially from those expressed in the Company's
forward-looking statements.
Readers are cautioned not to put undue reliance
on forward-looking statements, and the Company assumes no
obligation and does not intend to update or revise these
forward-looking statements, whether as a result of new information,
future events or otherwise.
For further information, please contact:
Investor ContactKCSA Strategic
CommunicationsPhil Carlson / Erika Kay iSpecimen@kcsa.com
Media ContactsKCSA Strategic
CommunicationsRaquel Cona / Shana Marino iSpecimen@kcsa.com
iSpecimen (NASDAQ:ISPC)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
iSpecimen (NASDAQ:ISPC)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024